Aimovig

Aimovig (Erenumab) is a subcutaneous injection used for migraine prevention. This medication is designed to reduce the frequency of migraine episodes in eligible patients.

Aimovig is primarily used for the prevention of migraines. It is not intended for the acute treatment of migraines once they have started. Erenumab works by targeting a protein involved in migraine attacks, helping to reduce their occurrence. Patients often wonder, 'What is Aimovig used for?' and the answer is focused on migraine prevention.

Common effects of Aimovig may include injection site reactions such as pain, redness, or swelling. Some users may also experience constipation or muscle tension. These effects are generally mild and temporary.

Aimovig should be used with caution in patients with a history of hypersensitivity to Erenumab or any of its components. It is important to follow the prescribed administration guidelines and consult a healthcare provider before use.

Aimovig may interact with other medications, particularly those that affect the cardiovascular system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.